Safety and Efficacy of Gevokizumab in Patients with Behçet's Disease Uveitis: Results of an Exploratory Phase 2 Study.
Tugal-Tutkun I Md, Kadayifcilar S Md, Khairallah M Md, Lee SC Md PhD, Ozdal P, Özyazgan Y, Song JH Md, Yu HG Md PhD, Lehner V PhD, de Cordoue A Md, Bernard O Md, Gül A Md.
Tugal-Tutkun I Md, et al.
Ocul Immunol Inflamm. 2017 Feb;25(1):62-70. doi: 10.3109/09273948.2015.1092558. Epub 2016 Jan 30.
Ocul Immunol Inflamm. 2017.
PMID: 26829647
Clinical Trial.